Skip to main content
. 2019 Dec 11;2019:3267207. doi: 10.1155/2019/3267207

Table 1.

Common HSP70 and HSP90 vaccines.

HSP vaccine Target carcinoma Clinical trial Reference
Vitepsin-Gp96-based vaccine Several-liver, ovarian, glioma, melanoma, etc. Phases II and III, approved in some places. [67]
HSP.PC 96-Gp96-based vaccine Renal carcinoma Phases II and III [68]
HSP. 70PC-HSP70-based vaccine Breast cancer Phase I [69]
HPV16oE7-HSP70-based vaccine Cervical cancer [50]